Your browser doesn't support javascript.
loading
European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.
Quinn, Terence J; Richard, Edo; Teuschl, Yvonne; Gattringer, Thomas; Hafdi, Melanie; O'Brien, John T; Merriman, Niamh; Gillebert, Celine; Huygelier, Hanne; Verdelho, Ana; Schmidt, Reinhold; Ghaziani, Emma; Forchammer, Hysse; Pendlebury, Sarah T; Bruffaerts, Rose; Mijajlovic, Milija; Drozdowska, Bogna A; Ball, Emily; Markus, Hugh S.
Afiliação
  • Quinn TJ; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
  • Richard E; Department of Neurology, Donders Institute for Brain, Behaviour and Cognition, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Teuschl Y; Department for Clinical Neurosciences and Preventive Medicine, Danube University Krems, Krems, Austria.
  • Gattringer T; Department of Neurology and Division of Neuroradiology, Vascular and Interventional Radiology, Department of Radiology, Medical University of Graz, Graz, Austria.
  • Hafdi M; Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • O'Brien JT; Department of Psychiatry, University of Cambridge School of Clinical Medicine, Cambridge, UK.
  • Merriman N; Department of Health Psychology, Division of Population Health Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Gillebert C; Department Brain and Cognition, Leuven Brain Institute, KU Leuven, Leuven, Belgium.
  • Huygelier H; TRACE, Centre for Translational Psychological Research (TRACE), KU Leuven - Hospital East-Limbourgh, Genk, Belgium.
  • Verdelho A; Department Brain and Cognition, Leuven Brain Institute, KU Leuven, Leuven, Belgium.
  • Schmidt R; TRACE, Centre for Translational Psychological Research (TRACE), KU Leuven - Hospital East-Limbourgh, Genk, Belgium.
  • Ghaziani E; Department of Neurosciences and Mental Health, Hospital de Santa Maria, Lisbon, Portugal.
  • Forchammer H; Department of Neurology and Medical University of Graz, Graz, Austria.
  • Pendlebury ST; Department of Physical and Occupational Therapy, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark.
  • Bruffaerts R; Hjernesagen, The Danish Stroke Association, Taastrup, Denmark.
  • Mijajlovic M; Departments of Medicine and Geratology and NIHR Oxford Biomedical Research Centre Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
  • Drozdowska BA; Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium.
  • Ball E; Neurosonology Unit, Neurology Clinic, University Clinical Center of Serbia and Faculty of Medicine University of Belgrade, Belgrade, Serbia.
  • Markus HS; Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK.
Eur J Neurol ; 28(12): 3883-3920, 2021 12.
Article em En | MEDLINE | ID: mdl-34476868
BACKGROUND AND PURPOSE: The optimal management of post-stroke cognitive impairment (PSCI) remains controversial. These joint European Stroke Organisation (ESO) and European Academy of Neurology (EAN) guidelines provide evidence-based recommendations to assist clinicians in decision making regarding prevention, diagnosis, treatment and prognosis. METHODS: Guidelines were developed according to the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology. The working group identified relevant clinical questions, performed systematic reviews, assessed the quality of the available evidence, and made specific recommendations. Expert consensus statements were provided where insufficient evidence was available to provide recommendations. RESULTS: There was limited randomized controlled trial (RCT) evidence regarding single or multicomponent interventions to prevent post-stroke cognitive decline. Lifestyle interventions and treating vascular risk factors have many health benefits, but a cognitive effect is not proven. We found no evidence regarding routine cognitive screening following stroke, but recognize the importance of targeted cognitive assessment. We describe the accuracy of various cognitive screening tests, but found no clearly superior approach to testing. There was insufficient evidence to make a recommendation for use of cholinesterase inhibitors, memantine nootropics or cognitive rehabilitation. There was limited evidence on the use of prediction tools for post-stroke cognition. The association between PSCI and acute structural brain imaging features was unclear, although the presence of substantial white matter hyperintensities of presumed vascular origin on brain magnetic resonance imaging may help predict cognitive outcomes. CONCLUSIONS: These guidelines highlight fundamental areas where robust evidence is lacking. Further definitive RCTs are needed, and we suggest priority areas for future research.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Disfunção Cognitiva / Neurologia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Acidente Vascular Cerebral / Disfunção Cognitiva / Neurologia Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur J Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article